Dementia and the heart failure patient

Wolfram Doehner, Wolfram Doehner

Abstract

Heart and brain disorders more frequently co-exist than by chance alone, due to having common risk factors and a degree of interaction. In the setting of heart failure (HF) in the elderly strokes, dementia, and depression are all common and can produce a particularly difficult series of clinical problems to manage. Loss of ability to self-care can lead to very poor quality of life and a dramatic increase in health care expenditure. The Heart Failure Association of the ESC as part of its workshop on physiological monitoring of the complex multi-morbid HF patient reviewed screening, monitoring, prevention, and management of cognitive decline within the setting of HF.

Keywords: Co-morbidities; Cognition; Dementia; Heart failure; Stroke.

Published on behalf of the European Society of Cardiology. © The Author(s) 2019.

References

    1. Scherbakov N, Doehner W.. Heart-brain interactions in heart failure. Card Fail Rev 2018;4:87–91.
    1. Britt HC, Harrison CM, Miller GC, Knox SA.. Prevalence and patterns of multimorbidity in Australia. Med J Aust 2008;189:72–77.
    1. Kohara K, Okada Y, Ochi M, Ohara M, Nagai T, Tabara Y, Igase M.. Muscle mass decline, arterial stiffness, white matter hyperintensity, and cognitive impairment: Japan Shimanami Health Promoting Program study. J Cachexia Sarcopenia Muscle 2017;8:557–566.
    1. Doehner W, Ural D, Haeusler KG, Čelutkienė J, Bestetti R, Cavusoglu Y, Peña-Duque MA, Glavas D, Iacoviello M, Laufs U, Alvear RM, Mbakwem A, Piepoli MF, Rosen SD, Tsivgoulis G, Vitale C, Yilmaz MB, Anker SD, Filippatos G, Seferovic P, Coats AJS, Ruschitzka F.. Heart and brain interaction in patients with heart failure: overview and proposal for a taxonomy. A position paper from the Study Group on Heart and Brain Interaction of the Heart Failure Association. Eur J Heart Fail 2018;20:199–215.
    1. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P.. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2016;18:891–975.
    1. van Bilsen M, Patel HC, Bauersachs J, Böhm M, Borggrefe M, Brutsaert D, Coats AJS, de Boer RA, de Keulenaer GW, Filippatos GS, Floras J, Grassi G, Jankowska EA, Kornet L, Lunde IG, Maack C, Mahfoud F, Pollesello P, Ponikowski P, Ruschitzka F, Sabbah HN, Schultz HD, Seferovic P, Slart R, Taggart P, Tocchetti CG, Van Laake LW, Zannad F, Heymans S, Lyon AR.. The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2017;19:1361–1378.
    1. Roy B, Woo MA, Wang DJJ, Fonarow GC, Harper RM, Kumar R.. Reduced regional cerebral blood flow in patients with heart failure. Eur J Heart Fail 2017;19:1294–1302.
    1. Erkelens CD, van der Wal HH, de Jong BM, Elting JW, Renken R, Gerritsen M, van Laar PJ, van Deursen VM, van der Meer P, van Veldhuisen DJ, Voors AA, Luijckx GJ.. Dynamics of cerebral blood flow in patients with mild non-ischaemic heart failure. Eur J Heart Fail 2017;19:261–268.
    1. Coats AJS. Early abnormalities of cerebral blood flow in mild non-ischaemic heart failure: part of a whole-body response? Eur J Heart Fail 2017;19:269–270.
    1. Hajduk AM, Lemon SC, McManus DD, Lessard DM, Gurwitz JH, Spencer FA, Goldberg RJ, Saczynski JS.. Cognitive impairment and self-care in heart failure. Clin Epidemiol 2013;5:407–416.
    1. Ampadu J, Morley JE.. Heart failure and cognitive dysfunction. Int J Cardiol 2015;178:12–23.
    1. Hanon O, Vidal J-S, de Groote P, Galinier M, Isnard R, Logeart D, Komajda M.. Prevalence of memory disorders in ambulatory patients aged C70 years with chronic heart failure (from the EFICARE Study). Am J Cardiol 2014;113:1205–1210.
    1. Zuccala G, Pedone C, Cesari M, Onder G, Pahor M, Marzetti E.. The effects of cognitive impairment on mortality among hospitalized patients with heart failure. Am J Med 2003;115:97–103.
    1. Pressler SJ, Subramanian U, Kareken D, Perkins SM, Gradus-Pizlo I, Sauvé MJ, Ding Y, Kim J, Sloan R, Jaynes H, Shaw RM.. Cognitive deficits in chronic heart failure. Nurs Res 2010;59:127–139.
    1. Alwerdt J, Edwards JD, Athilingam P, O’Connor ML, Valdes EG.. Longitudinal differences in cognitive functioning among older adults with and without heart failure. J Aging Health 2013;25:1358–1377.
    1. Nagai M, Dote K, Kato M.. Central command in heart failure: was there effect of hemispheric lateralization in insular cortex activation? Eur J Heart Fail 2018;20:1370.
    1. Doehner W, Čelutkienė J, Haeusler KG.. Central command in heart failure: was there effect of hemispheric lateralization in insular cortex activation? Reply Eur J Heart Fail 2018;20:1370–1371.
    1. Alosco ML, Brickman AM, Spitznagel MB, van Dulmen M, Raz N, Cohen R, Sweet LH, Colbert LH, Josephson R, Hughes J, Rosneck J, Gunstad J.. The independent association of hypertension with cognitive function among older adults with heart failure. J Neurol Sci 2012;323:216–220.
    1. Jankowska EA, Biel B, Majda J, Szklarska A, Lopuszanska M, Medras M, Anker SD, Banasiak W, Poole-Wilson PA, Ponikowski P.. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Circulation 2006;114:1829–1837.
    1. Čelutkienė J, Vaitkevičius A, Jakštienė S, Jatužis D.. Expert opinion-cognitive decline in heart failure: more attention is needed. Card Fail Rev 2016;2:106–109.
    1. Alagiakrishnan K, Mah D, Ahmed A, Ezekowitz J.. Cognitive decline in heart failure. Heart Fail Rev 2016;21:661–673.
    1. Cameron J, Worrall-Carter L, Page K, Stewart S, Ski CF.. Screening for mild cognitive impairment in patients with heart failure: montreal cognitive assessment versus mini mental state exam. Eur J Cardiovasc Nurs 2013;12:252–260.
    1. Jefferson AL, Tate DF, Poppas A, Brickman AM, Paul RH, Gunstad J, Cohen RA.. Lower cardiac output is associated with greater white matter hyperintensities in older adults with cardiovascular disease. J Am Geriatr Soc 2007;55:1044–1048.
    1. Almeida OP, Garrido GJ, Etherton-Beer C, Lautenschlager NT, Arnolda L, Alfonso H, Flicker L.. Brain and mood changes over 2 years in healthy controls and adults with heart failure and ischaemic heart disease. Congest Heart Fail 2013;19:E29–E34.
    1. Cogswell RJ, Norby FL, Gottesman RF, Chen LY, Solomon S, Shah A, Alonso A.. High prevalence of subclinical cerebral infarction in patients with heart failure with preserved ejection fraction. Eur J Heart Fail 2017;19:1303–1309.
    1. Meguro T, Meguro Y, Kunieda T.. Atrophy of the parahippocampal gyrus is prominent in heart failure patients without dementia. ESC Heart Fail 2017;4:632–640.
    1. Suzuki H, Matsumoto Y, Ota H, Sugimura K, Takahashi J, Ito K, Miyata S, Fukumoto Y, Taki Y, Shimokawa H.. Structural brain abnormalities and cardiac dysfunction in patients with chronic heart failure. Eur J Heart Fail 2018;20:936–938.
    1. Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M.. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J 2016;37:3232..
    1. Feigin VL, Mensah GA, Norrving B, Murray CJ, Roth GA; GBD 2013 Stroke Panel Experts Group. Atlas of the global burden of stroke (1990-2013): the GBD 2013 study. Neuroepidemiology 2015;45:230–236.
    1. Hebert K, Kaif M, Tamariz L, Gogichaishvili I, Nozadze N, Delgado MC, Arcement LM.. Prevalence of stroke in systolic heart failure. J Card Fail 2011;17:76–81.
    1. Kristensen SL, Jhund PS, Køber L, McKelvie RS, Zile MR, Anand IS, Komajda M, Cleland JG, Carson PE, McMurray JJ.. Relative importance of history of heart failure hospitalization and N-terminal Pro–B-type natriuretic peptide level as predictors of outcomes in patients with heart failure and preserved ejection fraction. JACC Heart Fail 2015;3:478–486.
    1. Haeusler KG, Laufs U, Endres M.. Chronic heart failure and ischemic stroke. Stroke 2011;42:2977–2982.
    1. Katsanos AH, Parissis J, Frogoudaki A, Vrettou AR, Ikonomidis I, Paraskevaidis I, Triantafyllou N, Kargiotis O, Voumvourakis K, Alexandrov AV, Tsivgoulis G.. Heart failure and the risk of ischemic stroke recurrence: a systematic review and meta-analysis. J Neurol Sci 2016;362:182–187.
    1. Kannel WB, Wolf PA, Verter J.. Manifestations of coronary disease predisposing to stroke. The Framingham study. JAMA 1983;250:2942–2946.
    1. Zannad F, Anker SD, Byra WM, Cleland JGF, Fu M, Gheorghiade M, Lam CSP, Mehra MR, Neaton JD, Nessel CC, Spiro TE, van Veldhuisen DJ, Greenberg B; COMMANDER HF Investigators. Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease. N Engl J Med 2018;379:1332–1342.
    1. Ma H, Campbell BCV, Parsons MW, Churilov L, Levi CR, Hsu C, Kleinig TJ, Wijeratne T, Curtze S, Dewey HM, Miteff F, Tsai CH, Lee JT, Phan TG, Mahant N, Sun MC, Krause M, Sturm J, Grimley R, Chen CH, Hu CJ, Wong AA, Field D, Sun Y, Barber PA, Sabet A, Jannes J, Jeng JS, Clissold B, Markus R, Lin CH, Lien LM, Bladin CF, Christensen S, Yassi N, Sharma G, Bivard A, Desmond PM, Yan B, Mitchell PJ, Thijs V, Carey L, Meretoja A, Davis SM, Donnan GA; EXTEND Investigators . Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. N Engl J Med 2019;380:1795–1803.
    1. Whiteley WN, Slot KB, Fernandes P, Sandercock P, Wardlaw J. Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies. Stroke 2012;43:2904–2909.
    1. Abdul-Rahim AH, Fulton RL, Frank B, McMurray JJ, Lees KR; VISTA collaborators . Associations of chronic heart failure with outcome in acute ischaemic stroke patients who received systemic thrombolysis: analysis from VISTA. Eur J Neurol 2015;22:163–169.
    1. Dalkara T, Alarcon-Martinez L.. Cerebral microvascular pericytes and neurogliovascular signaling in health and disease. Brain Res 2015;1623:3–17.
    1. Junger J, Schellberg D, Muller-Tasch T.. Depression increasingly predicts mortality in congestive heart failure. Eur J Heart Fail 2005;7:261–267.
    1. Wallenborn J, Angermann CE.. Comorbid depression in heart failure. Herz 2013;38:587–596.
    1. Ramos S, Prata J, Bettencourt P, Gonçalves FR, Coelho R.. Depression predicts mortality and hospitalization in heart failure: a six-years follow-up study. J Affect Disord 2016;201:162–170.
    1. O’Connor CM, Jiang W, Kuchibhatlla M, Sliva SG, Cuffe MS, Callwood DD, Zakhary B, Stough WG, Arias RM, Rivelli SK, Krishnan RSADHART-CHF Investigators. Safety and efficacy of sertraline for depression in patients with heart failure. Results of the SADHART-CHF (Setraline Against Depression and Heart Disease in Chronic Heart Failure) Trial. J Am Coll Cardiol 2010;56:692–699.
    1. Angermann CE, Gelbrich G, Stork S, Fallgatter A, Deckert J, Faller H, Ertl G, MOOD-HF Investigators. Rationale and design of a randomized, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF). Eur J Heart Fail 2007;9:1212–1222.
    1. Stewart Coats AJ, Shewan LG, Abraham WT.. The management of co-morbidities in patients with heart failure central sleep apnoea. Int Cardiovasc Forum J 2015;2:2.
    1. Madias JE. Heart-brain interactions in patients with heart failure, including takotsubo syndrome: a need to monitor autonomic sympathetic activity. Eur J Heart Fail 2018;20:1164.
    1. Amenta F, Mignini F, Rabbia F, Tomassoni D, Veglio F.. Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: analysis of published clinical trials. J Neurol Sci 2002;203–204:147–151.
    1. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033–1041.
    1. Zuccala G, Onder G, Marzetti E.. Use of ACE-inhibitors and variations in cognitive performance among patients with heart failure. Eur Heart J 2005;26:226–233.
    1. Ravenni R, Jabre J, Casiglia E, Mazza A.. Primary stroke prevention and hypertension treatment: which is the first-line strategy? Neurol Int 2011;3:12.
    1. McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR.. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014;371:993–1004.
    1. Alessio G, Lombardi F.. Neprilysin inhibition for heart failure. N Engl J Med 2014;371:2335–2337.
    1. Feldman AM, Haller JA, DeKosky ST.. Valsartan/sacubitril for heart failure; reconciling disparities between preclinical and clinical investigations. JAMA 2016;315:25–26.
    1. Cannon JA, Shen L, Jhund PS, Kristensen SL, Køber L, Chen F, Gong J, Lefkowitz MP, Rouleau JL, Shi VC, Swedberg K, Zile MR, Solomon SD, Packer M, McMurray JJ; PARADIGM-HF Investigators and Committees. Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction. Eur J Heart Fail 2017;19:129–137.
    1. McIlvennan CK, Magid KH, Ambardekar AV, Thompson JS, Matlock DD, Allen LA.. Clinical outcomes after continuous-flow LVED; a systematic review. Cir Heart Fail 2014;7:1003–1013.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere